Critical Roles of EGFR family members in breast cancer and breast cancer stem cells: Targets for therapy

Linda S. Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, Lucio Cocco, Matilde Y. Follo, Alberto M. Martelli, Luca M. Neri, Sandra Marmiroli, Massimo Libra, Saverio Candido, Ferdinando Nicoletti, Aurora Scalisi, Concettina Fenga, Lyudmyla Drobot, Dariusz Rakus, Agnieszka Gizak, Piotr Laidler, Joanna Dulińska-Litewka, Joerg Basecke, Sanja MijatovicDanijela Maksimovic-Ivanic, Giuseppe Montalto, Melchiorre Cervello, Michelle Milella, Agustino Tafuri, Zoya Demidenko, Stephen L. Abrams, James A. McCubrey

Research output: Contribution to journalArticlepeer-review

Abstract

The roles of the epidermal growth factor receptor (EGFR) signaling pathway in various cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck, hepatocellular, lung, neuroblastoma, ovarian, pancreatic, prostate, renal and other cancers have been keenly investigated since the 1980’s. While the receptors and many downstream signaling molecules have been identified and characterized, there is still much to learn about this pathway and how its deregulation can lead to cancer and how it may be differentially regulated in various cell types. Multiple inhibitors to EGFR family members have been developed and many are in clinical use. Current research often focuses on their roles and other associated pathways in cancer stem cells (CSCs), identifying sites where therapeutic resistance may develop and the mechanisms by which microRNAs (miRs) and other RNAs regulate this pathway. This review will focus on recent advances in these fields with a specific focus on breast cancer and breast CSCs. Relatively novel areas of investigation, such as treatments for other diseases (e.g., diabetes, metabolism, and intestinal parasites), have provided new information about therapeutic resistance and CSCs.

Original languageEnglish
Pages (from-to)2358-2388
Number of pages31
JournalCurrent Pharmaceutical Design
Volume22
Issue number16
Publication statusPublished - May 1 2016

Keywords

  • Cancer Stem Cells
  • Drug Resistance
  • EGFR
  • HER2
  • Metastasis
  • mIRs

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Critical Roles of EGFR family members in breast cancer and breast cancer stem cells: Targets for therapy'. Together they form a unique fingerprint.

Cite this